Amazon cover image
Image from Amazon.com

WHO Expert Committee on specifications for pharmaceutical preparations : fortieth report.

Material type: TextTextPublication details: Geneva, Switzerland : World Health Organization, c2006Description: iii, 461 pages ; 24 cmISBN:
  • 9789241209373
Subject(s): LOC classification:
  • RS 51 .W67 2006
Contents:
Introduction -- General Policy -- Quality control- specifications and tests -- Quality control- international Reference Materials -- Quality control- national laboratories -- Quality assurance- Good Manufacturing Practices -- Quality assurance- inspection -- Quality assurance- distribution -- Quality assurance- risk analysis -- Quality assurance- stability -- Prequalification -- Regulatory guidance on interchangeability for multisource (generic) pharmaceutical products -- Donations of medicine
Summary: This report presents the recommendations of an international group of experts convened by the World Health Organization to consider matters concerning the quality assurance of pharmaceuticals and specifications for drug substances and dosage forms. Annexes include: a list of available international chemical reference substances and international infrared spectra; supplementary guidelines on good manufacturing practices for heating, ventilation and air-conditioning systems for non-sterile pharmaceutical dosage forms; updated supplementary guidelines on good manufacturing practices for the manufacture of herbal medicines; supplementary guidelines on good manufacturing practices for validation; good distribution practices for pharmaceutical products; a model quality assurance system for procurement agencies (recommendations for quality assurance systems focusing on prequalification of products and manufacturers, purchasing, storage and distribution of pharmaceutical products); multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability; a proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms; and additional guidance for organizations performing in vivo bioequivalence studies.
Item type: Books
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Collection Call number Copy number Status Date due Barcode
Books Books National University - Manila LRC - Main General Circulation Pharmacy GC RS 51 .W67 2006 (Browse shelf(Opens below)) c.1 Available NULIB000009476

Includes bibliographical references.

Introduction -- General Policy -- Quality control- specifications and tests -- Quality control- international Reference Materials -- Quality control- national laboratories -- Quality assurance- Good Manufacturing Practices -- Quality assurance- inspection -- Quality assurance- distribution -- Quality assurance- risk analysis -- Quality assurance- stability -- Prequalification -- Regulatory guidance on interchangeability for multisource (generic) pharmaceutical products -- Donations of medicine

This report presents the recommendations of an international group of experts convened by the World Health Organization to consider matters concerning the quality assurance of pharmaceuticals and specifications for drug substances and dosage forms. Annexes include: a list of available international chemical reference substances and international infrared spectra; supplementary guidelines on good manufacturing practices for heating, ventilation and air-conditioning systems for non-sterile pharmaceutical dosage forms; updated supplementary guidelines on good manufacturing practices for the manufacture of herbal medicines; supplementary guidelines on good manufacturing practices for validation; good distribution practices for pharmaceutical products; a model quality assurance system for procurement agencies (recommendations for quality assurance systems focusing on prequalification of products and manufacturers, purchasing, storage and distribution of pharmaceutical products); multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability; a proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms; and additional guidance for organizations performing in vivo bioequivalence studies.

There are no comments on this title.

to post a comment.